Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
PUT
Ciena
CIEN
$60.7B
| $20.1M | 0.01% |
381,200
-334,800
| -47% | -$14.9M |
|
1702
Nutanix
NTNX
$18B
| $20.1M | 0.01% |
631,824
+179,811
| +40% | +$4.88M |
|
1703
PUT
State Street SPDR S&P Homebuilders ETF
XHB
$1.59B
| $20.1M | 0.01% |
349,300
-77,200
| -18% | -$4.36M |
|
|
AFMD
1704
DELISTED
Affimed
AFMD
| $20.1M | 0.01% |
345,912
+28,590
| +9% | +$1.35M |
|
1705
CALL
PennyMac Financial
PFSI
$4.05B
| $20.1M | 0.01% |
306,800
+245,900
| +404% | +$14.6M |
|
|
ANSS
1706
PUT
DELISTED
Ansys
ANSS
| $20.1M | 0.01% |
55,300
+18,900
| +52% | +$6.33M |
|
1707
Sherwin-Williams
SHW
$87.2B
| $20.1M | 0.01% |
82,005
-304,083
| -79% | -$72.1M |
|
1708
PUT
Wolfspeed
WOLF
$1.65B
| $20.1M | 0.01% |
189,700
+19,500
| +11% | +$1.57M |
|
1709
PUT
Lemonade
LMND
$4.07B
| $20M | 0.01% |
163,500
+109,700
| +204% | +$8.09M |
|
|
ACC
1710
DELISTED
American Campus Communities, Inc.
ACC
| $20M | 0.01% |
468,259
+363,668
| +348% | +$14.5M |
|
1711
CALL
Iron Mountain
IRM
$38.5B
| $20M | 0.01% |
679,300
-43,800
| -6% | -$1.22M |
|
1712
LKQ Corp
LKQ
$6.43B
| $20M | 0.01% |
568,089
+464,874
| +450% | +$15.9M |
|
1713
Veeva Systems
VEEV
$39.6B
| $20M | 0.01% |
73,495
-88,969
| -55% | -$24.9M |
|
1714
ICU Medical
ICUI
$4.58B
| $20M | 0.01% |
93,249
+75,506
| +426% | +$14.6M |
|
1715
CALL
ConocoPhillips
COP
$152B
| $20M | 0.01% |
498,900
-188,300
| -27% | -$6.94M |
|
1716
PUT
Thor Industries
THO
$4.11B
| $19.9M | 0.01% |
214,200
+91,800
| +75% | +$8.6M |
|
1717
Franco-Nevada
FNV
$45.2B
| $19.9M | 0.01% |
158,837
+96,096
| +153% | +$13M |
|
1718
Cemex
CX
$16B
| $19.9M | 0.01% |
3,842,889
+56,576
| +1% | +$259K |
|
|
ARNC
1719
DELISTED
Arconic Corporation
ARNC
| $19.8M | 0.01% |
666,083
+285,156
| +75% | +$7.5M |
|
1720
CALL
McKesson
MCK
$101B
| $19.8M | 0.01% |
114,100
+15,200
| +15% | +$2.53M |
|
1721
CALL
Editas Medicine
EDIT
$433M
| $19.8M | 0.01% |
282,800
+157,200
| +125% | +$6.46M |
|
1722
APA Corp
APA
$14.2B
| $19.8M | 0.01% |
1,396,117
-10,898,849
| -89% | -$127M |
|
1723
Corpay
CPAY
$27.4B
| $19.8M | 0.01% |
72,448
+55,024
| +316% | +$14.1M |
|
1724
Canadian Pacific Kansas City
CP
$82.2B
| $19.7M | 0.01% |
284,750
+177,255
| +165% | +$11.5M |
|
1725
Gen Digital
GEN
$17B
| $19.7M | 0.01% |
948,189
-811,445
| -46% | -$16.4M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.